Hydrocodone Extended-Release Capsules and Ranibizumab
Determining the interaction of Hydrocodone Extended-Release Capsules and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Capsules-Ranibizumab Intraocular
- Hydrocodone Extended-Release Capsules-Ranibizumab ophthalmic
- Hydrocodone Extended-Release Capsules-Ranitidine
- Hydrocodone Extended-Release Capsules-Ranitidine Capsule
- Hydrocodone Extended-Release Capsules-Ranitidine Hydrochloride
- Hydrocodone Extended-Release Capsules-Ranitidine Injection
- Ranibizumab-Hydrocodone Extended-Release Tablets
- Ranibizumab-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Ranibizumab-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Ranibizumab-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Ranibizumab-Hydrocortisone
- Ranibizumab-Hydrocortisone (Systemic)